Skip to the card

Card 341 of 9832026-09-12 issue

Observed arrival · 2026-09-12

HeartMend’s five-gene second read for cardiac biopsies

heartmendtechnology.org Observed source
Editorial interest 78/100 Selection signal · not a rating of the site

A molecular diagnostic panel that scores acute cellular rejection risk from the same tissue collected for routine heart-transplant biopsy.

Landing page captured for the 2026-09-12 issue.

Field notes

The workflow uses a portion of the same endomyocardial biopsy collected for routine histology, measures five named genes, and applies an L2-regularized logistic regression model without refitting to new cohorts. The site reports testing on 25 external biopsies—12 rejection and 13 non-rejection—after training on 43 separate samples, with 2,000 permutation-test label shuffles. These are site-reported validation figures, not evidence here of regulatory clearance or routine clinical deployment.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

OpenPublic substance visible
PrettyNotable craft visible
ProPolished or operationally mature
NicheUnusually specific use
HumanPersonal, local, civic, or handmade

One card from the complete issue

Radio Range Becomes Geography

352,465 arrived 1,000 judged 983 catalogued Enter the complete issue
heartmendtechnology.org

Landing page observed 2026-09-12. The live site may have changed.